HemoSense, Inc. Signs Agreement With Biodis For INRatio Distribution In France

SAN JOSE, Calif.--(BUSINESS WIRE)--May 4, 2006--HemoSense, Inc. (AMEX:HEM - News) today announced it has signed an exclusive distribution agreement with Biodis SA, a STAGO Group company, to market and distribute HemoSense’s portable INRatio® Prothrombin Time PT/INR Monitoring system for patient self testing in France. The agreement with Biodis represents the Company’s 16th international distribution agreement and expands HemoSense’s distributor reach to 22 countries internationally.

MORE ON THIS TOPIC